Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up

    61 Citations (Scopus)

    Abstract

    The study assessed long-term safety and efficacy of intramyocardial injection of autologous bone-marrow derived mesenchymal stromal cells (BMMSCs) in patients with severe stable coronary artery disease (CAD) and refractory angina.
    Original languageEnglish
    JournalInternational Journal of Cardiology
    Volume170
    Issue number2
    Pages (from-to)246-51
    Number of pages6
    ISSN0167-5273
    DOIs
    Publication statusPublished - 10 Dec 2013

    Fingerprint

    Dive into the research topics of 'Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up'. Together they form a unique fingerprint.

    Cite this